These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20620390)

  • 1. Statins and the risk of prostate cancer or benign prostatic hyperplasia: biological plausibility.
    Getzenberg RH
    J Urol; 2010 Aug; 184(2):415-6. PubMed ID: 20620390
    [No Abstract]   [Full Text] [Related]  

  • 2. How statins may increase prostate cancer.
    Goldstein MR; Mascitelli L; Pezzetta F
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):459. PubMed ID: 18268131
    [No Abstract]   [Full Text] [Related]  

  • 3. Statins may reduce risk of prostate cancer.
    Mayo Clin Health Lett; 2009 Aug; 27(8):4. PubMed ID: 19760800
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins may slow prostate growth.
    Printz C
    Cancer; 2012 Sep; 118(18):4369. PubMed ID: 22952030
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment.
    Garzotto M
    J Urol; 2010 Aug; 184(2):500. PubMed ID: 20620407
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment.
    Murtola T
    J Urol; 2010 Aug; 184(2):500. PubMed ID: 20620406
    [No Abstract]   [Full Text] [Related]  

  • 7. Statin use and risk of prostate cancer in a population of men who underwent biopsy.
    Tan N; Klein EA; Li J; Moussa AS; Jones JS
    J Urol; 2011 Jul; 186(1):86-90. PubMed ID: 21571344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
    Rittmaster RS
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and prostate cancer prevention: where we are now, and future directions.
    Murtola TJ; Visakorpi T; Lahtela J; Syvälä H; Tammela TLj
    Nat Clin Pract Urol; 2008 Jul; 5(7):376-87. PubMed ID: 18542103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The incidences of benign prostatic hyperplasia and prostatic cancer in China].
    Gu FL
    Zhonghua Wai Ke Za Zhi; 1993 Jun; 31(6):323-6. PubMed ID: 7508844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do statins protect against prostate cancer?
    Goldstraw MA; Amoroso P; Kirby RS
    BJU Int; 2006 Jun; 97(6):1147-8. PubMed ID: 16686701
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiologic musing on statin drugs in the prevention of advanced prostate cancer.
    Platz EA
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2175-80. PubMed ID: 17982117
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins and prostate cancer.
    Harv Mens Health Watch; 2009 May; 13(10):6-7. PubMed ID: 19489154
    [No Abstract]   [Full Text] [Related]  

  • 16. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
    Kristal AR; Arnold KB; Schenk JM; Neuhouser ML; Weiss N; Goodman P; Antvelink CM; Penson DF; Thompson IM
    J Urol; 2007 Apr; 177(4):1395-400; quiz 1591. PubMed ID: 17382740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Do statins protect against prostate cancer?
    Parkinson RJ; Jain S
    BJU Int; 2006 Sep; 98(3):691. PubMed ID: 16925779
    [No Abstract]   [Full Text] [Related]  

  • 18. Benign prostatic hyperplasia, prostate cancer and other prostate diseases diagnosed as a result of screening procedure among 1,004 men in the Lublin district.
    Opalińska E; Stoma F; Michalak A; Latalski M; Goniewicz M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):493-501. PubMed ID: 12898966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostate cancer--incidence and risk factors].
    Brasso K
    Ugeskr Laeger; 2007 May; 169(20):1883-6. PubMed ID: 17553361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.